Skip to main content
Medicine Man Technologies Inc. d/b/a Schwazze logo

Medicine Man Technologies Inc. d/b/a Schwazze — Investor Relations & Filings

Ticker · SHWZ NEO Wholesale and retail trade
Open in API
Filings indexed 239 across all filing types
Latest filing 2025-10-14 Regulatory Filings
Country CA Canada
Listing NEO SHWZ

About Medicine Man Technologies Inc. d/b/a Schwazze

https://schwazze.com/

Medicine Man Technologies Inc., operating as Schwazze, is a vertically integrated multi-state cannabis operator (MSO). The company manages the entire cannabis supply chain, encompassing cultivation, manufacturing, distribution, and retail sale of cannabis products. Schwazze focuses on establishing a premier regional presence, primarily targeting high-growth markets in Colorado and New Mexico. Utilizing a data-driven approach and an acquisitive growth strategy, the company aims to enhance operational efficiency and innovate the cannabis industry. Its retail portfolio includes diverse brands such as Star Buds, Emerald Fields, and R.Greenleaf, serving both medical and recreational segments.

Recent filings

Filing Released Lang Actions
Material document(s).pdf
Regulatory Filings
2025-10-14 English
Other material contracts - English.pdf
Board/Management Information Classification · 95% confidence The document is a United States SEC Form 8-K filed under Item 5.02 announcing the appointment of an Interim Chief Financial Officer and related compensatory arrangements. This is a disclosure of changes in senior management. According to the classification definitions, announcements of changes in the company’s board of directors or senior management fall under Board/Management Information (MANG).
2025-04-22 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings Classification · 91% confidence The document is Form 13-502F1, a mandatory fee calculation and management certification submitted to the Ontario Securities Commission under OSC Rule 13-502 Fees. It is not an earnings, annual, or interim report, nor a shareholder meeting material, share issuance, director dealing, or call transcript. Rather, it is a regulatory compliance filing for fee payment, fitting the fallback category for miscellaneous regulatory filings.
2025-04-03 English
Other.pdf
Regulatory Filings Classification · 85% confidence The document is a U.S. SEC Form 12b-25 “Notification of Late Filing,” which is a regulatory notice to the SEC about delayed periodic reports (Form 10-K, 10-Q), and does not contain substantive financial statements or earnings content. It is not the report itself but a regulatory filing advising of a late submission. This falls under the general regulatory filings fallback category.
2025-04-01 English
Other.pdf
Capital/Financing Update Classification · 81% confidence The document is a U.S. SEC Form 8-K current report disclosing a missed loan principal and interest payment by the company’s subsidiary, a default event, acceleration of obligations, default interest accrual, and actions by the collateral agent to control and sweep cash. This pertains to a significant change in the company’s financing and capital structure rather than an earnings release, share transaction, or AGM material. Therefore it falls under Capital/Financing Update (CAP).
2025-03-13 English
Material document(s).pdf
Regulatory Filings
2024-12-12 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.